Overview
Comparison of rate of complete abortion between Letrozole plus Misoprostol versus Misoprostol alone in first trimester pregnancy
Description
Comparison of rate of complete abortion between Letrozole plus Misoprostol versus Misoprostol alone in first trimester pregnancy; RCT
This reseach focus on the medical abortion in the early pregnancy loss. The target population is 70 patients (35 per group). We devide patient into 2 groups, intervention and control group. In intervention group we give the Letrozole 10 mg PO daily at day 1-3 prior to Misoprostol 800 mcg SL in day 4.
In control group we give only Misoprostol 800 mcg SL. Then, thepatien will follow up on day 7, TVS will be done to diagnose the complete abortion.
The primary outcome is rate of complete abortion between 2 groups. The secondary outcome is side effect of letrozole and induced to abortion time.
Eligibility
Inclusion Criteria:
- Diafnoed Early pregnancy loss by TVS according to ACOG Practice bulletin 2018
- GA <= 14 weeks
- Os open <= 1 cm and no conceptus per os
- Hematicrit >= 30
- Systolic blood pressure >= 95 mmHg
- Informed consent done and can follow up and comunicate in Thai language
Exclusion Criteria:
- Allerguc to Letrozole or Misoprostol
- Intrauterine contraceptive device use
- Breast feeding
- Diagnoed with ectopic pregnancy or undiagnoed adnexal mass
- Severe or recurrent liver disease or AST or ALT more than or equal to 3 times of upper normal limit
- Multiple pregnancy
- Myoma uteri that involves the endometrium ex. Submucous myoma uteri
- Thromboembolism or has a history of thromboembolism
- Serum creatinine >= 2